Skip to content

Evaluation of the Baha SoundArc in Pediatric Patients

Evaluation of the Baha SoundArc in Pediatric Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03333577
Enrollment
32
Registered
2017-11-07
Start date
2017-11-02
Completion date
2018-11-02
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss, Conductive, Hearing Loss, Mixed, Hearing Loss, Unilateral

Brief summary

The purpose of this study is to gather clinical performance data on the Baha SoundArc

Detailed description

Current Baha recipients that are using a Baha SoftBand will be recruited to be fitted with an alternative non-surgical option for using their Baha Sound Processor. The subjects will be tested with there existing Baha Sound Processor on the SoftBand and will then be fitted with the Baha SoundArc where they will perform a one month take home trial. At the end of this trial, the subject will return for testing and evaluation of their experience with this new fitting option.

Interventions

DEVICESoundArc

non-surgical attachment method for wearing a bone conduction hearing system

Sponsors

Cochlear
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

• Existing recipients using a Baha sound processor on a Softband for at least three months * Subjects aged 5 through 12 years of age * Subjects should be able to perform clinical testing adapted for age and developmental status, (Threshold sound field audiometry and basic monosyllabic word test, PBK) * Willingness on behalf of the subject's parent or guardian to complete study questionnaire

Exclusion criteria

• Subject's inability to perform requisite test measures as described in the study protocol \-

Design outcomes

Primary

MeasureTime frameDescription
Patient Satisfaction Surveyone month post fittingTo evaluate patient experience when using the Baha SoundArc after a one month take-home trial, compared to the existing Baha Softband on the Participant Take Home questionnaire (strongly agree, Agree, Neutral, disagree, strongly disagree)
Percentage Correct on Word Identification Task4 weeks post fittingone list of monosyllabic words (PBK words) was assessed at 60dBA, with word scores recorded as a percent correct.

Countries

United States

Participant flow

Participants by arm

ArmCount
Experimental SoundArc Study Group
all subjects will receive the SoundArc intervention SoundArc: non-surgical attachment method for wearing a bone conduction hearing system
25
Total25

Baseline characteristics

CharacteristicExperimental SoundArc Study Group
Age, Categorical
<=18 years
25 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 25
other
Total, other adverse events
1 / 25
serious
Total, serious adverse events
0 / 25

Outcome results

Primary

Patient Satisfaction Survey

To evaluate patient experience when using the Baha SoundArc after a one month take-home trial, compared to the existing Baha Softband on the Participant Take Home questionnaire (strongly agree, Agree, Neutral, disagree, strongly disagree)

Time frame: one month post fitting

ArmMeasureValue (NUMBER)
Experimental SoundArc Study GroupPatient Satisfaction Survey65 percentage of satisfied subjects
Primary

Percentage Correct on Word Identification Task

one list of monosyllabic words (PBK words) was assessed at 60dBA, with word scores recorded as a percent correct.

Time frame: 4 weeks post fitting

ArmMeasureValue (MEAN)Dispersion
Experimental SoundArc Study GroupPercentage Correct on Word Identification Task85.1 % corrrect wordsStandard Deviation 13.6

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026